134(top 1%)
papers
5.6K(top 1%)
citations
36(top 1%)
h-index
75(top 1%)
g-index
139
all documents
5.9K
doc citations
1.1K
citing journals

Top Articles

#TitleJournalYearCitations
1Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaLeukemia2008787
2Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2015458
3Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2021265
4Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsBlood2011259
5Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party databaseMultiple Sclerosis Journal2006206
6Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working GroupBlood2008190
7Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposureBlood2008164
8Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 studyBlood2011161
9Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphomaBlood2009157
10Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of Unmutated VH Gene in Patients With Chronic Lymphocytic LeukemiaJournal of Clinical Oncology2005137
11The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblingsBlood2001118
12New prognostic markers in chronic lymphocytic leukemiaBlood Reviews2008118
13Chronic lymphocytic leukemia and autoimmunity: a systematic reviewHaematologica2011117
14A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidenceLeukemia2010109
15The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphomaAnnals of Oncology2006107
16Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signalingBlood2013107
17Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease statusLeukemia2001105
18Smoldering (Asymptomatic) Multiple Myeloma: Current Diagnostic Criteria, New Predictors of Outcome, and Follow-Up RecommendationsJournal of Clinical Oncology2010101
19Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemiaLeukemia2002100
20Extramedullary multiple myeloma escapes the effect of thalidomideHaematologica2004100
21Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for LeukemiaClinical Cancer Research201598
22Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantationAnnals of Oncology201389
23How I treat refractory CLLBlood200685
24Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPIAmerican Journal of Hematology201779
25Transplantation for multiple myeloma: who, when, how often?Blood200376
26Monoclonal Gammopathy of Undetermined Significance: Predictors of Malignant Transformation and Recognition of an Evolving Type Characterized by a Progressive Increase in M Protein SizeMayo Clinic Proceedings200776
27Unrelated Cord Blood TransplantationTransplantation201366
28Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces ApoptosisPLoS ONE201164
29Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosisBlood201462
30Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow TransplantationBone Marrow Transplantation200755
31Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow TransplantationBone Marrow Transplantation201753
32Single Antigen–Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide Is a Suitable Alternative for Patients Lacking HLA-Matched DonorsBiology of Blood and Marrow Transplantation201850
33Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II StudyBiology of Blood and Marrow Transplantation200945
34Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agentsCytokine200841
35Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?Leukemia200238
36Incidence and Clinical Significance of Bcl-2 / IgH Rearrangements in Follicular LymphomaLeukemia and Lymphoma200337
37Bortezomib: A valuable new antineoplastic strategy in multiple myelomaActa Oncológica200535
38Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow TransplantationBone Marrow Transplantation201735
39Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemiaLeukemia200234
40Treatment of Chronic Lymphocytic Leukemia: Achieving Minimal Residual Disease–Negative Status As a GoalJournal of Clinical Oncology200534
41Life expectancy of young adults with follicular lymphomaAnnals of Oncology201531
42Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response durationEuropean Journal of Haematology200630
43Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer CenterCancer201830
44Thalidomide in refractory and relapsing multiple myelomaSeminars in Oncology200129
45Chronic lymphocytic leukaemia: a short overviewAnnals of Oncology200829
46Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMTJournal of Hematology and Oncology202127
47Myelofibrosis with myeloid metaplasia in adult individuals 30 years old or younger: presenting features, evolution and survivalEuropean Journal of Haematology200126
48Survivin expression in the progression of chronic myeloid leukemia: A sequential study in 16 patientsLeukemia and Lymphoma200526
49Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemiaCytometry Part B - Clinical Cytometry200626
50Management of Complications in Multiple MyelomaSeminars in Hematology200926